What We're Reading: Page 162
Industry reads hand-picked by our editors
May 27, 2021
May 26, 2021
-
The Wall Street Journal
Two College Pals Reunite After 50 Years in Race for Covid-19 Vaccines
-
Evaluate Vantage
Lilly leads the big pharma pack on pipeline value
-
STAT
Most clinical trials are still not reported on time to federal database
May 25, 2021
-
STAT
A gene therapy opens a new chapter for children, but challenges endure
-
Reuters
UK regulator reviewing AstraZeneca's $39 billion Alexion buyout
-
Science
I'm subject NL002-0060 and I'm dropping out of my COVID-19 vaccine trial
-
Endpoints News
AbbVie's last stand: How an Icelandic billionaire's biosimilar has one final shot to dethrone Humira
May 24, 2021
-
Endpoints News
Inside Vertex 3.0: Can Reshma Kewalramani repeat one of biotech's biggest success stories 'again and again and again'?
-
The New York Times
These Sisters With Sickle Cell Had Devastating, and Preventable, Strokes
-
The Sunday TImes
Ministers fear forced sale of GlaxoSmithKline
-
Reuters
U.S. CDC looking into heart inflammation in some young vaccine recipients
May 21, 2021
-
Fast Company
Tory Burch and Nobel Prize winner Jennifer Doudna are teaming up to help women scientists
-
In The Pipeline
CRISPR Editing in Primates
-
Chemical & Engineering News
To conquer COVID-19, create the perfect pill
-
Fierce Biotech
RenBio joins bigwigs Eli Lilly, Regeneron in hunt for next gen COVID-19 antibodies after $24M financing
May 20, 2021
May 19, 2021
-
STAT
How Ashish Jha became network TV’s everyman expert on Covid
-
BBC
Vaccinating children before poor morally wrong, Oxford scientist says
-
Nature
Kinase drug discovery 20 years after imatinib: progress and future directions
-
Reuters
India unlikely to resume sizable COVID-19 vaccine exports until October
Previous
